You are here

Article Text

Article menu
Download PDFPDF
Prognosis
Cohort study
Appointment and medication non-adherence is associated with increased mortality in insulin-treated type 2 diabetes
  1. Lindsay Bundrick Harrison,
  2. Ildiko Lingvay
  1. Department of Internal Medicine, Division of Endocrinology, UT Southwestern Medical Center, Dallas, TX, USA
  1. Correspondence to
    Dr Ildiko Lingvay, UT Southwestern Medical Center, 5323 Harry Hines Blvd, Dallas, TX 75390-8857, USA; ildiko.lingvay{at}utsouthwestern.edu

https://doi.org/10.1136/eb-2012-100912

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Commentary on: Currie CJ, Peyrot M, Morgan CL, et al. The impact of treatment noncompliance on mortality in people with type 2 diabetes. Diabetes Care 2012; 35: 1279– 84.OpenUrlAbstract/FREE Full Text

    Context

    Diabetes increases the risk of death twofold; identifying novel modifiable risk factors could improve patient outcomes and focus healthcare spending in areas with the highest return. Non-adherence to prescribed medications and clinic appointments may be independent risk factors for excess mortality.

    Methods

    Currie and colleagues performed a database review of insulin-treated patients with type 2 diabetes who followed up for 6 months prior to insulin initiation and at least 30 months post-insulin initiation during which compliance with any medications and appointments were evaluated. Mortality was assessed from the end of 36 months (index date) which fell between 2000 and 2009. Information from 15 984 charts was collected until death or …

    View Full Text

    Footnotes

    • Competing interests None.